Skip to content

Evaluation of the Auxiliary Effect of Supplementing Lysine Calcium Magnesium Zinc Liquid Drink on Children's Growth, a Single-center, Randomized, Double-blind, Placebo-controlled Clinical Study

Evaluation of the Auxiliary Effect of Supplementing Lysine Calcium Magnesium Zinc Liquid Drink on Children's Growth, a Single-center, Randomized, Double-blind, Placebo-controlled Clinical Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124846
Enrollment
Unknown
Registered
2026-05-18
Start date
2026-05-18
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Test Group:Lysine Calcium Magnesium Zinc Liquid Drink (Witsbb Grow Pro+ TalPlax Drink 2)
Placebo Group:Placebo

Sponsors

Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 8-14 years old, regardless of sex; 2. height-for-age Z score less than -1, those who have just entered puberty; 3. fully understand the nature, purpose, benefits, and potential risks and side effects of this study, and can objectively cooperate with physicians to complete the examination and evaluation of disease and physical condition; 4. those who voluntarily agree and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who have used or are using growth hormone, whose epiphyseal plates have closed, with abnormal thyroid function, type 1 diabetes, tumors, abnormal liver and kidney function; 2. those with diseases that severely affect the digestion and absorption of the trial supplies; 3. subjects with symptomatic and difficult-to-control neurological, psychiatric diseases or mental disorders; 4. those allergic to the components of the test food; 5. those taking supplemental foods and health supplements with the same efficacy within 4 weeks before the trial and during the trial.

Design outcomes

Primary

MeasureTime frame
Blood routine indicators;Blood biochemistry indicators;Urinalysis indicators;25-hydroxy vitamin D panel;Blood minerals: 9 trace elements (including lead and cadmium);Thyroid function: five thyroid function items;Blood osteocalcin (OST), bone alkaline phosphatase;Blood insulin-like growth factor-1;Sex hormones: six sex hormone items + SHBG LH FSH E2 T PRL PGN;gm4 quantitative food allergen;Bone density: lumbar spine bone density, left hip joint bone density, right hip joint bone density;Abdominal ultrasound D (liver, gallbladder, pancreas, spleen + lymph nodes);Human metabolic dynamics measurement analysis;Dietary assessment and dietary guidance;

Countries

China

Contacts

Public ContactHongmei Huang

Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health

huanghongmay@aliyun.com+86 10 5961 7123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026